Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Spero Therapeutics Inc
(NQ:
SPRO
)
10.95
USD
-0.15 (-1.35%)
Official Closing Price
/ Updated:
4:44 PM EDT, Aug 14, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
135,600
Open
11.10
Bid (Size)
10.92 (2)
Ask (Size)
14.35 (1)
Prev. Close
11.10
Today's Range
10.46 - 11.12
52wk Range
9.660 - 19.00
Shares Outstanding
14,377,753
Dividend Yield
N/A
Performance
YTD
-9.80%
-9.80%
1 Month
-6.41%
-6.41%
3 Month
-10.47%
-10.47%
6 Month
-2.23%
-2.23%
1 Year
-4.78%
-4.78%
Top News
More News
Spero Announces Appointment of John C. Pottage, Jr., MD to its Board of Directors
August 14, 2018
Spero adds broad leadership and scientific expertise to its Board of Directors with appointment of John Pottage
Read More
from
GlobeNewswire News Releases
Spero Therapeutics Announces Second Quarter 2018 Financial Results and Pipeline Overview
August 09, 2018
Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR)...
Read More
from
GlobeNewswire News Releases
More News
Read More
Spero Awarded up to $54 Million by BARDA and DTRA to Support SPR994 Development
July 16, 2018
from
GlobeNewswire News Releases
Spero Therapeutics Announces Pricing of Securities Offering
July 12, 2018
from
GlobeNewswire News Releases
Spero Therapeutics Announces Proposed Offering of Common Stock
July 09, 2018
from
GlobeNewswire News Releases
Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
July 09, 2018
from
GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within Jabil, Gladstone Investment, Spero Therapeutics, Jagged Peak Energy, Sabre, and Zions — New Research Emphasizes Economic Growth
June 11, 2018
from
GlobeNewswire News Releases
Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018
June 06, 2018
from
PR Newswire
Spero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018
June 05, 2018
from
GlobeNewswire News Releases
Spero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June
June 01, 2018
from
GlobeNewswire News Releases
Spero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform
May 23, 2018
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
